PhaseBio Pharmaceuticals Inc reports

Company location: Malvern, PA
Fiscal year end: 31 December

PhaseBio Pharmaceuticals Inc has filed 371 SEC EDGAR filings since 25 Feb 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 51-75 of 364 matching filings.

Per page

25

Current page

3

8-K File 001-38697

8-K

Filing date: 27 Sep 2022
Reporting date: 21 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38697

10-Q

Filing date: 12 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38697

8-K

Filing date: 12 Aug 2022
Reporting date: 12 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38697

8-K

Filing date: 08 Aug 2022
Reporting date: 04 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-90691

SC 13G/A filing

Filing date: 19 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38697

8-K

Filing date: 05 Jul 2022
Reporting date: 29 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4/A

FORM 4/A

Filing date: 10 Jun 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 May 2022
Reporting date: 20 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 May 2022
Reporting date: 20 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 May 2022
Reporting date: 20 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 May 2022
Reporting date: 20 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 May 2022
Reporting date: 20 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 May 2022
Reporting date: 20 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A

Filing date: 20 May 2022
Reporting date: 18 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38697

8-K

Filing date: 20 May 2022
Reporting date: 19 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38697

10-Q

Filing date: 16 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38697

8-K

Filing date: 16 May 2022
Reporting date: 16 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEF 14A File 001-38697

DEFA14A

Filing date: 22 Apr 2022
Reporting date: 22 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .